Long COVID — symptoms persisting more than 12 weeks after acute SARS-CoV-2 infection — is associated with roughly 40 percent higher risk of new-onset diabetes in the year after infection, according to large cohort studies and ongoing NIH RECOVER research. Mechanisms under investigation include persistent inflammation, viral reservoir effects, autoimmune triggering, microvascular dysfunction, and stress hormone elevation. Symptoms of long COVID overlap with diabetes symptoms, so screening post-COVID patients with fasting glucose and A1C is a reasonable approach in higher-risk groups.
What Is Long COVID
Long COVID, also called post-acute sequelae of SARS-CoV-2 infection (PASC), is defined by symptoms that persist or emerge more than 12 weeks after the acute infection and cannot be explained by another diagnosis. The WHO uses a similar definition, while the NIH RECOVER project applies a research definition based on a symptom score.
Common Long COVID Symptoms
- Fatigue, often disproportionate to activity
- Cognitive difficulty — memory, concentration, word-finding (brain fog)
- Shortness of breath
- Palpitations, orthostatic intolerance, POTS-like presentation
- Sleep disturbance
- Loss or alteration of smell and taste
- Headaches
- Muscle and joint pain
- Gastrointestinal symptoms
- Mood symptoms
The Diabetes Signal in Long COVID Research
| Data Source | Reported Finding |
|---|---|
| VA Million Veteran cohort | ~40 percent higher diabetes incidence in year after COVID |
| UK CPRD primary-care data | Elevated new diabetes diagnoses post-COVID, especially in severe cases |
| CoviDIAB Project Registry | Documents new-onset COVID-associated diabetes cases globally |
| NIH RECOVER | Ongoing prospective cohort; metabolic substudies in progress |
| Pediatric series | Cases of new type 1 diabetes after COVID, sometimes with DKA |
The relative risk is larger for severe COVID and seems to attenuate over time. Whether COVID truly causes new diabetes or unmasks pre-existing risk is still being characterized.
Mechanisms Under Investigation
Persistent Inflammation
- Elevated C-reactive protein and inflammatory cytokines months after acute infection
- Inflammation impairs insulin signaling in muscle, fat, and liver
- Adipose tissue inflammation contributes
Direct Beta-Cell Injury
- ACE2 receptor expression on pancreatic beta cells
- Post-mortem and biopsy series show SARS-CoV-2 RNA in pancreatic tissue in some severe cases
- May reduce functional beta-cell mass even after viral clearance
Autoimmune Triggering
- Viral infection is a classical trigger for autoimmune diabetes
- Cases of new type 1 diabetes with positive GAD or IA-2 antibodies after COVID
- Molecular mimicry and bystander activation are plausible
Microvascular Dysfunction
- Endothelial injury from acute COVID may persist
- Reduced muscle microvascular insulin delivery
- Possible link to long COVID exercise intolerance
Stress Hormones and Lifestyle
- Cortisol elevation during prolonged illness
- Reduced physical activity from fatigue worsens insulin resistance
- Weight changes, sleep disturbance, and altered eating patterns
Symptom Overlap with Diabetes
Several long COVID symptoms overlap with new-onset diabetes, which can delay recognition.
| Symptom | Long COVID | New Diabetes |
|---|---|---|
| Fatigue | Common | Common |
| Cognitive fog | Common | Can occur with high glucose |
| Weight loss | Sometimes | Common in new T1D and uncontrolled T2D |
| Increased thirst | Less common | Common |
| Increased urination | Less common | Common |
| Blurred vision | Sometimes | Common with high glucose |
| Slow wound healing | Rare | Common |
| Recurrent yeast or skin infections | Rare | Common |
Screening Recommendations
- Fasting glucose and A1C at 3 to 6 months post-COVID if symptoms persist
- Random glucose at any clinical visit with new fatigue, weight loss, or polyuria
- OGTT for borderline A1C values
- Autoantibody panel (GAD, IA-2, ZnT8) for young, lean, or rapidly progressing presentations
- C-peptide if insulin reserve is uncertain
The diagnostic thresholds are the same as for non-COVID diabetes — see our piece on diabetes diagnostic criteria.
Managing Diabetes in the Long COVID Setting
Glycemic Management
- Standard treatment principles apply — metformin, GLP-1 RA, SGLT2 inhibitors, insulin as indicated
- Be mindful of fatigue, which may limit gym-based exercise
- Continuous glucose monitoring can help patients with variable activity tolerance
- Watch for hypoglycemia in patients with reduced food intake
Activity and Pacing
- Graded return to physical activity
- Pacing strategies for post-exertional symptom exacerbation
- Resistance training tolerated better than long aerobic sessions in some patients
- Cardiac evaluation if exercise intolerance is severe
Diet and Sleep
- Mediterranean-style or DASH eating patterns
- Adequate hydration
- Sleep hygiene — long COVID often disrupts sleep, which worsens glucose
- Address mood symptoms; depression and anxiety impair self-care
Multidisciplinary Care
- Primary care
- Endocrinology for complex cases
- Long COVID clinic referral when available
- Rehabilitation, mental health, cardiology, pulmonology as needed
Special Populations
People with Pre-Existing Diabetes
- Many report worsened glucose control after COVID, lasting weeks to months
- Insulin needs often rise temporarily
- Re-evaluate medications and monitor more closely during recovery
Children and Adolescents
- New type 1 diabetes diagnoses, sometimes with DKA, reported after COVID
- Pediatric long COVID studies continue
Pregnancy
- Gestational diabetes risk may be elevated after acute COVID
- Standard screening at 24 to 28 weeks remains appropriate
What Patients Can Do
- Track symptoms, weight, and activity to share with the care team
- Ask about A1C and fasting glucose at follow-up visits
- Watch for warning signs — increased thirst, unexplained weight loss, blurred vision
- Maintain vaccination per current schedule
- Connect with long COVID patient resources and support communities
Related Reading
See our companion piece on COVID and diabetes for acute illness management. For foundational information on diabetes classification and risk, see what causes diabetes and prediabetes basics.
The Bottom Line
Long COVID is associated with roughly 40 percent higher risk of new-onset diabetes in the year after acute SARS-CoV-2 infection, with mechanisms likely including persistent inflammation, direct beta-cell injury, autoimmune triggering, microvascular dysfunction, and stress hormone elevation. Symptoms overlap with diabetes — fatigue, weight changes, brain fog — making screening important when symptoms persist. People with established diabetes often report worsening control after COVID and may need temporary treatment intensification. Patients with persistent post-COVID symptoms should talk to their clinician about a fasting glucose and A1C check, especially if they have other risk factors.
